GEL-DEL TECHNOLOGIES

Gel-Del Technologies is a biomedical device company making thermoplastic biomaterial technologies that mimic the body's tissues using revolutionary and patented protein based fabrication techniques. With its patented technology, Gel-Del has designed and produced products in the laboratory such as cosmetic tissue fillers, blood vessel grafts and implanted oral and particle drug delivery systems that are far superior to existing FDA-approved products, including many other products in the pipeline ... (e. g., cardiovascular stent and catheter coatings ). The Company has injected and/or implanted their proprietary biomaterial as cosmetic, orthopedic and cardiovascular products into animals with great results over the past ten years. Indeed, Gel-Del's regenerative biomaterial in the form of injected dermal filler particles, CosmetaLife, were used in a successfully completed FDA-approved clinical trial to treat facial wrinkles. This human trial met its primary efficacy and safety endpoints over a 12 month period in 150 subject, multi-center, double blind, split-face design study versus Control injections with Restylane, a hyaluronic acid biomaterial. No serious adverse effects were reported since being injected over five years ago.More